Reference
Song Q, et al. Neoadjuvant immunotherapy plus chemotherapy and adjuvant targeted therapy in ALK-positive non-small-cell lung cancer. Immunotherapy 15 : 809-817, No. 11, May 2023. Available from: URL: http://www.futuremedicine.com/loi/imt
Rights and permissions
About this article
Cite this article
Pembrolizumab. Reactions Weekly 1972, 294 (2023). https://doi.org/10.1007/s40278-023-45675-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-45675-1